Literature DB >> 26661480

Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells.

Anna Han1, Natalie Bennett1, Amber MacDonald1, Megan Johnstone1, Jay Whelan1, Dallas R Donohoe1.   

Abstract

Dietary fiber has been suggested to suppress colorectal cancer development, although the mechanisms contributing to this beneficial effect remain elusive. Butyrate, a fermentation product of fiber, has been shown to have anti-proliferative and pro-apoptotic effects on colorectal cancer cells. The metabolic fate of butyrate in the cell is important in determining whether, it acts as an HDAC inhibitor or is consumed as a short-chain fatty acid. Non-cancerous colonocytes utilize butyrate as the primary energy source whereas cancerous colonocytes increase glucose utilization through the Warburg effect. In this study, we show that butyrate oxidation is decreased in cancerous colonocytes compared to non-cancerous colonocytes. We demonstrate that colorectal cancer cells utilize both a carnitine-dependent and carnitine-independent mechanism that contributes to butyrate oxidation. The carnitine-dependent mechanism is contingent on butyrate concentration. Knockdown of CPT1A in colorectal cancer cells abolishes butyrate oxidation. In terms of selectivity, the carnitine-dependent mechanism only regulated butyrate oxidation, as acetate and propionate oxidation were carnitine-independent. Carnitine decreased the action of butyrate as an HDAC inhibitor and suppressed induction of H3 acetylation by butyrate in colorectal cancer cells. Thus, diminished oxidation of butyrate is associated with decreased HDAC inhibition and histone acetylation. In relation to the mechanism, we find that dichloroacetate, which decreases phosphorylation of pyruvate dehydrogenase, increased butyrate oxidation and that this effect was carnitine-dependent. In conclusion, these data suggest that colorectal cancer cells decrease butyrate oxidation through inhibition of pyruvate dehydrogenase, which is carnitine-dependent, and provide insight into why butyrate shows selective effects toward colorectal cancer cells. J. Cell. Physiol. 231: 1804-1813, 2016.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26661480     DOI: 10.1002/jcp.25287

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

Review 1.  Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance.

Authors:  Sean M McNabney; Tara M Henagan
Journal:  Nutrients       Date:  2017-12-12       Impact factor: 5.717

2.  Oral administration of propionic acid during lactation enhances the colonic barrier function.

Authors:  Zhaobo Xia; Yijiang Han; Ke Wang; Shikun Guo; Dazhou Wu; Xiaozhong Huang; Zhongrong Li; Libin Zhu
Journal:  Lipids Health Dis       Date:  2017-03-23       Impact factor: 3.876

Review 3.  Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways.

Authors:  Jiezhong Chen; Kong-Nan Zhao; Luis Vitetta
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

Review 4.  Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis.

Authors:  Pan Chen; Xiangqi Tang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

5.  Butyrate Alters Pyruvate Flux and Induces Lipid Accumulation in Cultured Colonocytes.

Authors:  Anna F Bekebrede; Thirza van Deuren; Walter J J Gerrits; Jaap Keijer; Vincent C J de Boer
Journal:  Int J Mol Sci       Date:  2021-10-10       Impact factor: 5.923

6.  Association of levels of metabolites with the safe margin of rectal cancer surgery: a metabolomics study.

Authors:  Shaopeng Zhang; Guoqiang Pan; Zhifeng Liu; Yuan Kong; Daguang Wang
Journal:  BMC Cancer       Date:  2022-10-05       Impact factor: 4.638

Review 7.  Compartmentalised acyl-CoA metabolism and roles in chromatin regulation.

Authors:  Sophie Trefely; Claudia D Lovell; Nathaniel W Snyder; Kathryn E Wellen
Journal:  Mol Metab       Date:  2020-02-14       Impact factor: 7.422

8.  Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases.

Authors:  Anna Han; Natalie Bennett; Bettaieb Ahmed; Jay Whelan; Dallas R Donohoe
Journal:  Oncotarget       Date:  2018-06-05

9.  Prognostic implications of metabolism-associated gene signatures in colorectal cancer.

Authors:  Yandong Miao; Qiutian Li; Jiangtao Wang; Wuxia Quan; Chen Li; Yuan Yang; Denghai Mi
Journal:  PeerJ       Date:  2020-09-02       Impact factor: 2.984

10.  A network pharmacology approach for investigating the multi-target mechanisms of Huangqi in the treatment of colorectal cancer.

Authors:  Xiao-Dong Chu; Yi-Ran Zhang; Zheng-Bin Lin; Zhan Zhao; Shu-Chen Huangfu; Sheng-Hui Qiu; Yan-Guan Guo; Hui Ding; Ting Huang; Xiao-Li Chu; Jing-Hua Pan; Yun-Long Pan
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.